Clinical trial
Prospective Randomized Controlled Study on Arthroscopic Treatment Combined With PRP Injection for Refractory Elbow Epicondylitis
NCT04556825 is registered in ClinicalTrials.gov with Beijing Jishuitan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Controlled Study on Arthroscopic Treatment Combined With PRP Injection for Refractory Elbow Epicondylitis
- Lead sponsor
- Beijing Jishuitan Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- July 1, 2024
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lateral epicondylitis, prp